Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04974489 · ClinicalTrials.gov registry record · NA
Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 1,153
- Enrollment target
NCT04974489 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,153 participants.
The verdict
NCT04974489, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,153 participants
- Enrollment target
Study Summary
Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has announced a comprehensive approach to tobacco and nicotine regulation that includes moving toward a very low nicotine content (VLNC) standard for cigarettes. Greatly reduced nicotine levels would facilitate smoking cessation. However, the maximal success of the policy may require public understanding that, although these new cigarettes are less addictive, their high toxicity and carcinogenicity are unchanged. Yet, nearly half of adult smokers incorrectly think smoking VLNC cigarettes is less harmful than smoking current cigarettes (the VLNC misperception). Additionally, 24% of smokers said they would be less likely to quit if a VLNC regulation is enacted. Thus, the VLNC misperception may partially undermine a nicotine reduction policy. Although communication research suggests it is challenging to change people's incorrect understanding, new communication techniques may help reduce the VLNC misperception. In this randomized trial we will examine whether messages about the harm of VLNC cigarettes can reduce the VLNC misperception and increase intention to quit in a nicotine reduction scenario.
Interventions
- BEHAVIORAL Emotion-based messages about the harm of VLNC
- BEHAVIORAL Continued-harm-framed messages about the harm of VLNC
- BEHAVIORAL Myth-refuting messages about the harm of VLNC
- BEHAVIORAL Control messages about littering
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,153 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2021-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04974489
The ClinicalTrials.gov registry entry for NCT04974489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Emotion-based messages about the harm of VLNC is the first listed.
NCT04974489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04974489 about?
NCT04974489 is a clinical study titled "Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes". Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has an...
What is the current status of trial NCT04974489?
This trial is currently completed. It is a NA study. The enrollment target is 1,153 participants. The study started on 2021-07-01. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT04974489?
The interventions under investigation include: Emotion-based messages about the harm of VLNC (BEHAVIORAL), Continued-harm-framed messages about the harm of VLNC (BEHAVIORAL), Myth-refuting messages about the harm of VLNC (BEHAVIORAL), Control messages about littering (BEHAVIORAL).
Who is sponsoring clinical trial NCT04974489?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.